Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT01708603

Public ClinicalTrials.gov record NCT01708603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and efficacy of brodalumab at two different doses

Study identification

NCT ID
NCT01708603
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
1,831 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2012 (Type not available)
Primary completion
Sep 2014 (Actual)
Completion
Oct 2015 (Actual)
Last update posted
Jan 6, 2020

2012 – 2015

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
59
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233 —
Research Site Tucson Arizona 85710 —
Research Site Hot Springs Arkansas 71913 —
Research Site Bakersfield California 93309 —
Research Site Beverly Hills California 90211 —
Research Site Irvine California 92697 —
Research Site Los Angeles California 90027 —
Research Site Los Angeles California 90045 —
Research Site Sacramento California 95816 —
Research Site San Diego California 92103 —
Research Site San Diego California 92123 —
Research Site Vista California 92083 —
Research Site Denver Colorado 80209 —
Research Site Denver Colorado 80210 —
Research Site Denver Colorado 80239 —
Research Site New Haven Connecticut 06511 —
Research Site Aventura Florida 33180 —
Research Site Jacksonville Florida 32216 —
Research Site Miami Florida 33136 —
Research Site Pembroke Pines Florida 33028 —
Research Site Tampa Florida 33612 —
Research Site Atlanta Georgia 30342 —
Research Site Newnan Georgia 30263 —
Research Site Snellville Georgia 30078 —
Research Site Chicago Illinois 60611 —
Research Site Chicago Illinois 60654 —
Research Site Skokie Illinois 60077 —
Research Site Carmel Indiana 46032 —
Research Site Plainfield Indiana 46168 —
Research Site South Bend Indiana 46617 —
Research Site Louisville Kentucky 40202 —
Research Site Lake Charles Louisiana 70601 —
Research Site Lake Charles Louisiana 70605 —
Research Site New Orleans Louisiana 70112 —
Research Site Rockville Maryland 20850 —
Research Site Silver Spring Maryland 20902 —
Research Site Boston Massachusetts 02114 —
Research Site Boston Massachusetts 02115 —
Research Site North Andover Massachusetts 01845 —
Research Site Ann Arbor Michigan 48109 —
Research Site Fridley Minnesota 55432 —
Research Site Omaha Nebraska 68144 —
Research Site Henderson Nevada 89074 —
Research Site Brooklyn New York 11209 —
Research Site New York New York 10029 —
Research Site Rochester New York 14625 —
Research Site Charlotte North Carolina 28210 —
Research Site Durham North Carolina 27710 —
Research Site Raleigh North Carolina 27612 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Beachwood Ohio 44122 —
Research Site Columbus Ohio 43212 —
Research Site Gahanna Ohio 43230 —
Research Site South Euclid Ohio 44118 —
Research Site Portland Oregon 97239 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Anderson South Carolina 29621 —
Research Site Mt. Pleasant South Carolina 29464 —
Research Site Austin Texas 78759 —
Research Site Dallas Texas 75246 —
Research Site Houston Texas 77065 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78249 —
Research Site West Jordan Utah 84088 —
Research Site Norfolk Virginia 23502 —
Research Site Roanoke Virginia 24016 —
Research Site Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01708603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2020 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01708603 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →